ASRT Stock Drops After-Hours On Discounted Buyout Deal

Under the deal, Garda Therapeutics will pay Assertio shareholders $18 per share in cash and a contingent value right.
Global stock market chart and trading board - stock photo
Representative image of stock market chart on a glowing particle world map and trading board. (Photo by Yuichiro Chino/Getty Images)
Profile Image
Anan Ashraf·Stocktwits
Published Apr 08, 2026   |   4:23 PM EDT
Share
·
Add us onAdd us on Google

Shares of Assertio Holdings, Inc. (ASRT) fell 1.5% after hours on Wednesday after the company said that it has entered into an agreement to be acquired by Garda Therapeutics for a total cash consideration of $125.1 million.

Under the deal, Garda will pay Assertio shareholders $18 per share in cash and a contingent value right. The cash consideration represents a 3% discount to the stock’s closing price on Tuesday.

The transaction is expected to close in the second quarter of 2026 and is subject to customary closing conditions, the pharmaceutical company said. 

Get updates to this developing story directly on Stocktwits.

Follow on Google News
Read about our editorial guidelines and ethics policy